BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 32587645)

  • 1. External validation of a prediction model for pathologic N2 among patients with a negative mediastinum by positron emission tomography.
    Farjah F; Backhus LM; Varghese TK; Manning JP; Cheng AM; Mulligan MS; Wood DE
    J Thorac Dis; 2015 Apr; 7(4):576-84. PubMed ID: 25973222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variational Autoencoders-BasedSelf-Learning Model for Tumor Identification and Impact Analysis from 2-D MRI Images.
    Naga Srinivasu P; Krishna TB; Ahmed S; Almusallam N; Khaled Alarfaj F; Allheeib N
    J Healthc Eng; 2023; 2023():1566123. PubMed ID: 36704578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Positron Emission Tomography in the Examination of Hilar and Mediastinal Lymphadenopathies in Patients with Suspicion of Lung Cancer.
    Pereiro-Brea T; Golpe-Gómez A; Golpe-Sánchez AM; Valdés L; Martínez de Alegría A; Carreira-Villamor JM; Ruano-Raviña A
    Can Respir J; 2020; 2020():7909543. PubMed ID: 32587645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
    Chin R; Ward R; Keyes JW; Choplin RH; Reed JC; Wallenhaupt S; Hudspeth AS; Haponik EF
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):2090-6. PubMed ID: 8520780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging for the study of mediastinal adenopathies in lung cancer: Comparison with standard tests.
    Pereiro-Brea T; de Alegría AM; Valdés L; Golpe-Gómez A; Carreira-Villamor JM; Ruano-Raviña A
    J Cancer Res Ther; 2021; 17(4):917-924. PubMed ID: 34528542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Positron emission tomography/computed tomography for lung cancer staging].
    Ladrón de Guevara H D; Furnaro L F; Yévenes A S; Clavero R JM; Lazo P D; Rodríguez D P; Piottante B A; Pefaur D R; Pardo B C
    Rev Med Chil; 2015 Jan; 143(1):22-9. PubMed ID: 25860265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer.
    Smith DE; Fernandez Aramburu J; Da Lozzo A; Montagne JA; Beveraggi E; Dietrich A
    Updates Surg; 2019 Dec; 71(4):741-746. PubMed ID: 31552569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
    Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
    Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Magnetic Resonance Imaging for N-Staging in Patients with Non-Small Cell Lung Cancer. A Systematic Review.
    Brea TP; Raviña AR; Villamor JMC; Gómez AG; de Alegría AM; Valdés L
    Arch Bronconeumol (Engl Ed); 2019 Jan; 55(1):9-16. PubMed ID: 29803524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Postmus PE; Kerr KM; Oudkerk M; Senan S; Waller DA; Vansteenkiste J; Escriu C; Peters S;
    Ann Oncol; 2017 Jul; 28(suppl_4):iv1-iv21. PubMed ID: 28881918
    [No Abstract]   [Full Text] [Related]  

  • 12. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings.
    Bustos García de Castro A; Ferreirós Domínguez J; Delgado Bolton R; Fernández Pérez C; Cabeza Martínez B; García García-Esquinas M; Carreras Delgado JL
    Radiologia; 2017; 59(2):147-158. PubMed ID: 28238444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
    Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
    BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Eighth Edition Lung Cancer Stage Classification.
    Detterbeck FC; Boffa DJ; Kim AW; Tanoue LT
    Chest; 2017 Jan; 151(1):193-203. PubMed ID: 27780786
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.